Sources: Company press releases and public filings. Market cap is approximate and fluctuates daily.
Key Milestones — Q4 2025 to Q1 2026
Sourced from company press releases filed on SEDAR+ and GlobeNewsWire.
New California Payer Contract
Now in-network with another major insurer for commercial employer-sponsored health plans across California, adding approximately 175,000 members. Total U.S. in-network reach extends to over 13 million covered lives.
+175K membersAlea Health Acquisition Completed
Closed the acquisition of Alea Health Holdings Ltd., adding an AI-powered mental health platform with conversational AI and voice technology for patient intake, follow-up, and 24/7 mental health support.
Mental health capabilities addedPrivate Placement Closed — Oversubscribed
Completed a non-brokered private placement of 7,428,571 units at C$0.70 per unit for gross proceeds of approximately C$5.2 million, upsized due to investor demand.
~C$5.2M raisedCAN Health Network — Alberta CDSS Pilot
Partnered with CAN Health Network to test its AI-powered Clinical Decision Support System at up to four primary care sites in Alberta. Targets 25–40% intake time reduction. Goal: province-wide expansion across 4,400+ providers.
Up to 4 pilot sitesQ3 2025 — Continued Revenue Growth
Organic quarter-over-quarter revenue growth continued. Announced signed in-network contracts with major U.S. insurers across Medicare Advantage, VA, Commercial, and Medicaid Managed Care in NY, CA, and MD.
13M+ in-network membersNIH SBIR Grant Awarded
Treatment USA, in collaboration with Rush River Research, was awarded a competitive NIH Small Business Innovation Research (SBIR) grant from the National Institute on Minority Health and Health Disparities.
NIH-funded researchTwo Integrated Assets in One Company
Rocket Doctor AI operates two interconnected businesses: a revenue-generating virtual care platform and a proprietary clinical AI engine.
Source: Company materials and public filings
Rocket Doctor — The Virtual Care Platform
A digital health marketplace enabling 300+ physicians to independently launch and manage virtual or hybrid practices. 700,000+ patient visits across four Canadian provinces and three U.S. states. In-network with payers covering over 13 million lives including Medicaid, Medicare Advantage, VA, and commercial plans.
Global Library of Medicine (GLM)
A physician-curated clinical decision support system developed over 9 years with input from hundreds of physicians. Covers 1,000+ diseases and 17,000+ symptoms. Uses structured, validated clinical data with audit trails — designed to triage, diagnose differentially, and adjust recommendations as new patient data is entered.
A Complete Virtual Care Pathway
The platform supports the full patient journey — from initial search and curated AI powered triage through physician visit, lab orders, follow-up, and chronic care management.
Source: Company materials
Curated Clinical AI vs. Generative AI
Management has highlighted key areas where the Global Library of Medicine is designed to differ from generative AI approaches.
Source: Company materials and industry comparison
Curated, Not Generative
Content built through structured development and physician-led review. Every data point is physician-validated with full audit trails.
Dynamic Differential Diagnosis
The platform recalculates diagnoses as new patient details emerge — including lab results and imaging — adjusting the differential in real time.
Multiple Deployment Options
Powers chatbots, voice assistants, and avatars. Designed for white-labeling, multilingual deployment, and EMR/telehealth integration behind client firewalls.
Supporting Next Generation Medical Education
A non-medical undergraduate using the system correctly diagnosed 11 of 12 patients in a medical school-level exam — 92% vs. a typical passing threshold of 60–70%.
The Healthcare AI Landscape
A comparison of public and private healthcare AI company valuations, based on publicly available data. Valuations are approximate and sourced from company disclosures and reported funding rounds.
Competitor valuations based on most recently reported funding rounds. Not a recommendation to buy or sell any security.
Path Forward
Management's publicly announced priorities, subject to successful execution and market conditions.
Rocket Doctor Acquisition & Revenue Integration
Platform acquired April 2025. Revenue with 89% gross margin reported on Q2 earnings.
Alea Health Acquisition
Closed January 8, 2026. Added AI-powered 24/7 mental health capabilities.
U.S. Payer Network to 13M+ Lives
In-network across Medicaid, Medicare Advantage, VA, and commercial plans in CA, NY, MD.
Alberta CDSS Pilot with CAN Health Network
AI-powered clinical decision support at up to four primary care sites. Dec 2025 – Mar 2026.
U.S. Physician & Patient Rampup
Ad campaigns launched Dec 2025.
RD Health Voyager — LLM Patient History Synthesis
In development. Uses LLMs to summarize patient medical histories from notes, labs, and intake forms.
Key Figures
Based on the most recent public filings and press releases.
Market cap approximate. Financial data per company filings. Covered lives per press releases.
Download the Rocket Doctor Investor Deck
Get the full overview of Rocket Doctor's AI-powered healthcare platform, market opportunity, and growth strategy.
Download the Rocket Doctor Deck →Stay Updated on Rocket Doctor
Get updates on Rocket Doctor developments and catalysts delivered to your inbox.
Unsubscribe anytime. No spam, just updates that matter.
DISCLOSURE: 45 Degrees, Inc. has been engaged by Rocket Doctor AI (formerly Treatment.com International Inc.) to provide marketing services under a six-month agreement commencing July 18, 2025, for total compensation of USD $180,000 plus 400,000 stock options exercisable at CAD $0.45. The principal of 45 Degrees also owns common shares of the company. See full disclaimer below.
Disclaimer This page contains content created by 45 Degrees, Inc., which operates StockTok.org. This page is disseminated on behalf of Rocket Doctor AI Inc. (formerly Treatment.com International Inc.). Compensation Disclosure 45 Degrees, Inc. of Cheyenne, WY, has been engaged by Rocket Doctor AI Inc. (the "Company") under a Marketing Engagement commencing July 18, 2025, for a six-month term to provide advertising services including Google Ads, social media, and video interview distribution. Total compensation under the Marketing Engagement is USD $180,000, payable in two equal installments: USD $90,000 on signing and USD $90,000 due 10 weeks after the marketing campaign launch. The Marketing Engagement may be extended on a month-to-month basis for a fee of USD $25,000 per month by mutual written agreement. The Company may also elect to increase the scope of services for accelerated reach, expanded content, or live media for an additional USD $10,000 per month. In connection with the Marketing Engagement, the Company has issued 400,000 stock options to the principal of 45 Degrees, each exercisable at CAD $0.45 per common share, vesting immediately with a 3-year exercise period. The principal of 45 Degrees also owns common shares of the Company and may buy or sell shares at any time. Readers should assume a conflict of interest exists. 45 Degrees, Inc. is not a securities dealer, broker, investment adviser, or financial adviser, and you should not rely on the information herein as investment advice. This page is informational only and is solely for use by prospective investors in determining whether to seek additional information. This does not constitute an offer to sell or a solicitation of an offer to buy any securities.
Forward-Looking Statements
This page contains forward-looking statements about Rocket Doctor AI Inc., identified by terms such as "anticipate," "expect," "target," and "project." These statements reflect current views regarding company performance and business goals. They involve various risks and uncertainties, including potential delays, financial difficulties, operational challenges, and competitive pressures. Actual results may differ significantly from what is described. Readers should not place undue reliance on these statements, which are only valid as of the page's last update and we undertake no obligation to update.
Nothing on this page should be construed as investment advice. Always consult a licensed investment advisor before making financial decisions. Review all public filings at sedarplus.ca and sec.gov.
1601 Central Ave, Cheyenne, WY 82001
Phone: +1.672.906.2276
Email: info@45degrees.media
© 2026 45 Degrees, Inc. All rights reserved.